Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection
- PMID: 39030064
- PMCID: PMC11283887
- DOI: 10.1016/S2214-109X(24)00210-9
Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection
Abstract
Cardiovascular diseases remain the number one cause of death globally. Cardiovascular disease risk scores are an integral tool in primary prevention, being used to identify individuals at the highest risk and guide the assignment of preventive interventions. Available risk scores differ substantially in terms of the population sample data sources used for their derivation and, consequently, in the absolute risks they assign to individuals. Differences in cardiovascular disease epidemiology between the populations contributing to the development of risk scores, and the target populations in which they are applied, can result in overestimation or underestimation of cardiovascular disease risks for individuals, and poorly informed clinical decisions. Given the wide plethora of cardiovascular disease risk scores available, identification of an appropriate risk score for a target population can be challenging. This Review provides an up-to-date overview of guideline-recommended cardiovascular disease risk scores from global, regional, and national contexts, evaluates their comparative characteristics and qualities, and provides guidance on selection of an appropriate risk score.
Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests SK reports grants from British Heart Foundation, grants from National Institute for Health and Care Research, and grants from Health Data Research UK, during the conduct of the Review. All other authors declare no competing interests.
Figures

Similar articles
-
Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP).Eur Heart J Acute Cardiovasc Care. 2020 Aug;9(5):522-532. doi: 10.1177/2048872619858285. Epub 2019 Jun 25. Eur Heart J Acute Cardiovasc Care. 2020. PMID: 31303009 Review.
-
Overview of Risk-Estimation Tools for Primary Prevention of Cardiovascular Diseases in European Populations.Cent Eur J Public Health. 2015 Jun;23(2):91-9. doi: 10.21101/cejph.a4004. Cent Eur J Public Health. 2015. PMID: 26851417 Review.
-
Overestimation and underestimation of cardiovascular risk in clinical practice: usefulness of risk estimation charts.Hellenic J Cardiol. 2007 Nov-Dec;48(6):341-5. Hellenic J Cardiol. 2007. PMID: 18196656
-
Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study.Eur J Prev Cardiol. 2018 Mar;25(4):420-431. doi: 10.1177/2047487317743352. Epub 2017 Nov 24. Eur J Prev Cardiol. 2018. PMID: 29171772 Free PMC article.
-
A comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and Examination Survey 1998.Eur J Cardiovasc Prev Rehabil. 2005 Oct;12(5):442-50. doi: 10.1097/01.hjr.0000183909.52118.9f. Eur J Cardiovasc Prev Rehabil. 2005. PMID: 16210930
Cited by
-
Cardiovascular Risk Assessment and Lipid-Lowering Therapy Recommendations in Primary Prevention.J Clin Med. 2025 Mar 25;14(7):2220. doi: 10.3390/jcm14072220. J Clin Med. 2025. PMID: 40217673 Free PMC article. Review.
-
Troponin Testing for Cardiovascular Primary Prevention Decision Making?J Am Coll Cardiol. 2025 Apr 15;85(14):1485-1487. doi: 10.1016/j.jacc.2025.02.026. J Am Coll Cardiol. 2025. PMID: 40204377 No abstract available.
-
Association between immune checkpoint inhibitors and cardiovascular risks: a nationwide self-controlled case series study.Am J Cancer Res. 2025 Apr 15;15(4):1820-1828. doi: 10.62347/ZUUA2691. eCollection 2025. Am J Cancer Res. 2025. PMID: 40371149 Free PMC article.
-
Korean Cardiovascular Health Status Assessed by Life's Essential 8 in Korean Adult Population: Based on Data From the Korean National Health and Nutrition Examination Survey 2014-2021.Korean Circ J. 2025 Aug;55(8):736-752. doi: 10.4070/kcj.2024.0411. Epub 2025 Apr 30. Korean Circ J. 2025. PMID: 40537421 Free PMC article.
-
Harnessing Electronic Health Records and Artificial Intelligence for Enhanced Cardiovascular Risk Prediction: A Comprehensive Review.J Am Heart Assoc. 2025 Mar 18;14(6):e036946. doi: 10.1161/JAHA.124.036946. Epub 2025 Mar 13. J Am Heart Assoc. 2025. PMID: 40079336 Free PMC article. Review.
References
-
- Leong DP, Joseph PG, McKee M, et al. Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease. Circ Res. 2017;121:695–710. - PubMed
-
- Pecka M, Kieslichová S, Malý J. European guidelines on cardiovascular disease prevention in clinical practice. Vnitr Lek. 2016;2016:2315–2381.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources